Document is current
Any future updates will be listed below
-
Authors
D’Amato, Marina
van der Laak, Jeroen
Ciompi, Francesco
-
Funding
Funding for this research was provided by:
Innovative Medicines Initiative (945358, 945358, 945358)
- License Information
-
More Information
Article History
Received: 10 June 2025
Accepted: 3 November 2025
First Online: 4 December 2025
Declarations
:
: Jeroen van der Laak is a member of the advisory boards of Philips, the Netherlands and ContextVision, Sweden, and received research funding from Philips, the Netherlands, ContextVision, Sweden, and Sectra, Sweden. He is chief scientific officer and a shareholder of Aiosyn BV, the Netherlands. Francesco Ciompi is shareholder of Aiosyn BV, the Netherlands. All the remaining authors declare no conflict of interest.
